Objective The first symptom of giant cell arteritis (GCA) is usually a headache. Japan has a low prevalence of GCA, and clinical features of this disorder have not been fully investigated. We conducted a retrospective evaluation of clinical features in patients with giant cell arteritis who visited a headache clinic in Japan. Methods Clinical and demographic data were obtained from clinical examinations, face-to-face interviews, and hospital records. Patients Subjects comprised 19 patients (9 men, 10 women). Results Mean age at disease onset was 78.1 ± 4.8 years (range, 71-86 years). Seventeen of 19 patients (89.5%) had consulted other medical institutions before consulting our hospital, but only 2 of those patients had been diagnosed with GCA at these medical institutions. Manifestations at disease onset included headache (89.5%), ear pain (5.3%), and jaw pain (5.3%). Ocular manifestations were reported in 2 patients (10.5%). No loss of vision occurred. One patient showed trigeminal nerve palsy involving the third division of the nerve. Jaw claudication was observed in 3 patients (15.8%). Concomitant polymyalgia rheumatica was seen in 3 patients (15.8%). No patient showed upper respiratory tract symptoms, arm claudication, or aortic aneurysms. Conclusion Although most patients had consulted other medical institutions before consulting our hospital, they were not diagnosed with GCA at these institutions. Infrequent clinical findings of GCA and lack of symptoms other than headache may contribute to the high rate of unrecognized and misdiagnosed cases of GCA.
Introduction
Giant cell arteritis (GCA) is a polysymptomatic disease of the elderly that mainly involves large-and medium-sized arteries, particularly the branches of the proximal aorta (1) . New-onset headache is the most frequent symptom, occurring in two thirds of patients (1) . The prevalence of GCA varies widely by geographic region, with the highest rates in northern European countries and the northern United States (!20 per 100,000 people >50 years old (2, 3) and lower rates in Arabia (4) and northwestern Turkey (5) . According to a nationwide survey (6) , Japan has been reported to show a lower prevalence of GCA than Western countries (1.47 per 100,000 population >50 years old), but few data are available regarding the clinical features of GCA in Japan. For example, a questionnaire-based nationwide survey (6) examined the clinical features of GCA, but only 66 cases were included. Other studies have been conducted in Japan, but these studies have only analyzed a small number of cases or have published case reports written in Japanese.
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Patients and Methods
Subjects comprised 19 patients diagnosed with GCA between May 2001 and November 2008 in the Department of Neurology at our hospital. In all cases, the diagnosis of GCA was based on the American College of Rheumatology criteria (9) . Clinical and demographic data for patients were obtained from clinical examinations, face-to-face interviews, and hospital records. This study was approved by the ethics committee of Japanese Red Cross Shizuoka Hospital, and the study was conducted in accordance with the ethical standards described in the Declaration of Helsinki.
Hospital setting
Our hospital is located in Shizuoka City, which has a population of about 726,000 and 8 general hospitals. The population within our medical care zone is about 94,000, with about 41,000>50 years old (10) .
Results

Patient characteristics
Subjects comprised 19 patients (9 men, 10 women; male: female ratio, 1 : 1.1). Table 1 shows diagnostic criteria for all patients. Mean (± standard deviation) age at disease onset was 78.1±4.8 years (range, 71-86 years). The mean interval from onset to diagnosis was 2.2±2.0 months (range, 4 days-6 months). Mean duration of follow-up was 41.0±30.0 months (range, 3-100 months). Seventeen of 19 patients (89.5%) had consulted other medical institutions before consulting our hospital, but only 2 of those patients had been diagnosed with GCA at these medical institutions. Departments consulted for undiagnosed patients included neurology, neurosurgery, rheumatology, and general physicians. Three patients (15.8%) came from outside our medical care zone.
Clinical manifestations
Manifestations at disease onset included headache in 17 patients (89.5%), ear pain in 1 (5.3%), and jaw pain in 1 (5.3%). Sites of headache were the temporal area in 12 (63.2%), occipital area in 2 (10.5%), frontal area in 2 (10.5%), and whole area in 1 (5.3%). Ten patients (52.6%) had pulsating headache, and 9 patients (47.4%) had nonpulsating headache. Headache intensity was severe in 8 (42.1%), moderate in 7 (36.8%), and mild in 4 (21.1%). Eleven patients (57.9%) had persistent headaches and 8 patients (42.1%) had paroxysmal headache. Ten patients (52.6%) felt general fatigue, 5 patients (26.3%) had fever, and 3 patients (15.8%) had weight loss. Ocular manifestations were reported in 2 patients (10.5%), with right oculomotor nerve palsy in 1 patient and right oculomotor combined with abducens nerve palsy in the other patient. No patient reported loss of vision. One patient (11) showed trigeminal nerve palsy involving the third division of the nerve. Jaw claudication was observed in 3 patients (15.8%). Concomitant polymyalgia rheumatica (PMR) was seen in 3 patients (15.8%). PMR was diagnosed before GCA in 1 patient, simultaneous with GCA in 1 patient, and after GCA in 1 patient. No patient showed upper respiratory tract symptoms, arm claudication, or aortic aneurysms.
Temporal artery abnormalities
Eighteen patients (94.7%) had temporal artery tenderness, 10 patients (52.6%) showed prominent or enlarged temporal arteries, and 8 patients (42.1%) displayed absent or reduced temporal artery pulse.
Laboratory findings
Elevated erythrocyte sedimentation rate (ESR) (>50 mm/ h) was recorded in 16 (84.2%) of patients. Ultrasonography of the temporal artery was performed in 6 of 19 patients, re- vealing halo sign and stenosis in 5 of these 6 patients. The remaining patient who underwent ultrasonography showed no abnormal findings, such as halo sign, stenosis, or occlusion.
Biopsy and angiography
Biopsy of the temporal artery was performed in 15 of 19 patients. Characteristic histological findings (mononuclear cell infiltration, granulomatous inflammation, or multinucleated giant cells) were revealed in 11 of 15 patients (73.3%). Patients with biopsy-confirmed GCA displayed no significant differences from biopsy-negative patients in terms of gender, age at diagnosis, or ESR. All patients with halo sign on ultrasonography showed characteristic histological findings. Angiography was performed in 4 of 19 patients (21.1%), revealing stenosis of the temporal artery in 3 patients. Stenosis, obstruction, aneurysm, or dilation of the carotid subclavian or axillary arteries was not observed in the 4 patients who underwent angiography.
Treatment and efficacy
All patients were diagnosed with GCA at our hospital and were treated with prednisolone, with 6 (31.6%) receiving < 40 mg/day and 13 (68.4%) receiving 40-60 mg/day. One patient was treated with methylprednisolone before prednisolone therapy. No patient was treated with cytotoxic drugs, cyclophosphamide, azathioprine, or methotrexate.
Complications
During steroid treatment, 1 patient experienced exacerbation of dementia. No patient showed any other major complications, such as infectious disease, gastrointestinal ulcer, cerebral infarction, or blindness.
Prognosis and cause of death
All patients showed improvement with initial steroid treatment, although 5 patients (26.3%) relapsed during steroid treatment. Three patients (15.8%) had histories of malignant tumors and 1 patient developed cancer of the large intestine after 5 years. Three patients died, 1 due to aspiration pneumonia, 1 due to recurrent gastric cancer, and 1 from cancer of the large intestine (1 patient at 1 year after completion of therapy). No patient showed development of aortic aneurysms.
Discussion
Clinical manifestations of CGA in our study appeared similar to a previous Japanese survey (6) ( Table 2 ). The previous Japanese survey demonstrated that PMR (30.3%), jaw claudication (15.2%), and complete vision loss (6.2%) among Japanese patients with GCA were less frequent compared with those reported in Western countries (1, (12) (13) (14) (15) , Turkey (5) and Tunisia (16) (39-74%, 16-58%, and 14-16%, respectively). Frequency of jaw claudication in our study (15.8%) was as same as that of the previous Japanese survey, but frequencies of PMR and complete vision loss in the present study (15.8% and 0%) were less than those in the previous Japanese survey. Data from the previous Japanese survey were collected from 14 departments, including de-partments of rheumatology, ophthalmology, and otorhinolaryngology. The present data were obtained from patients who consulted with the department of neurology. This difference in data sampling may explain the different prevalence of vision loss and complications of PMR between the previous Japanese survey and our study.
The present findings demonstrate that GCA remains unrecognized or misdiagnosed in many cases. In our study, 17 of 19 patients (89.5%) had consulted other medical institutions before consulting our hospital, but only 2 (10.5%) had been diagnosed with GCA by these medical institutions. Infrequent clinical findings of permanent or complete visual loss, jaw claudication, and PMR may contribute to the high rate of unrecognized and misdiagnosed cases. The numerous unrecognized or misdiagnosed cases in our study may mean that the prevalence of GCA in Japan was underestimated in the previous Japanese survey in 2003, in which the prevalence of GCA was estimated at 1.47 per 100,000 population >50 years old (6) . Based on that finding, the prevalence of GCA patients in our medical zone would be estimated at about 4.52 patients per 100,000 population >50 years old during our research period; however, we treated 16 patients living within our medical zone in this period. The spread of Western living habits and the rapid increase in the number of elderly people may affect the increasing prevalence of GCA. However, 7 years (from 2003 to 2010) is not long enough to account for such a dramatic change in disease prevalence. Our study demonstrated infrequent clinical findings other than headache and numerous unrecognized or misdiagnosed cases of GCA patients in Japan. These unrecognized and misdiagnosed cases may be due to a lack of clinical findings associated with GCA, other than headache. A diagnosis of CGA should be considered in all elderly patients with new-onset headache.
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